Current consensus recommendations for rheumatoid arthritis therapy: a blind spot for osteoporosis prevention and treatment
Jolles, B.M.; Bogoch, E.R.
Journal of Rheumatology 29(9): 1814-1817
2002
ISSN/ISBN: 0315-162X PMID: 12233871 Document Number: 541244
Document emailed within 1 workday
Related Documents
Shostak, N.A.; Muradiants, A.A.; Kondrashov, A.A.; Denisova, S.N. 2014: Clinical efficacy instant goat milk in the complex therapy and prevention of osteoporosis in patients with rheumatoid arthritis Voprosy Pitaniia 83(5): 79-85Wentworth, H.A. 1931: Variations of the normal blind spot with special reference to the formation of a diagnostic scale. I. The form blind spot. II. The color blind spot American Journal of Ophthalmol 14(9-11): 889-904, 1118-1131
Dawes, P.T.; Fowler, P.D. 1995: Treatment of early rheumatoid arthritis: a review of current and future concepts and therapy Clinical and Experimental Rheumatology 13(3): 381-394
Grana, J.; Mahia, I.V.; Meizoso, M.-O.S.; Vazquez, T. 2008: Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis) Clinical and Experimental Rheumatology 26(2): 384-385
Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Lange, U.; Illgner, U.; Teichmann, J.; Schleenbecker, H. 2004: Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study International Journal of Clinical Pharmacology Research 24(2-3): 33-38
Valesini, G.; Montecucco, C.; Cutolo, M. 2006: Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy Clinical and Experimental Rheumatology 24(4): 413-423
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Shiokawa, Y.; Horiuchi, T.; Honma, M.; Kageyama, T.; Okada, T. 1977: Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test Ryumachi 17(2): 205-210
Kleber, M.; Klinger, G.; Mieler, I.; Zuhrt, R.; Ehrke, H.; Grimm, W.D.; Kötzschke, H.; Nossek, H.; Seefeld, G.; Sponholz, H. 1986: Current recommendations for prevention, diagnosis and therapy of diseases of the periodontium Stomatologie der DDR 36(10): 560-566
Pinals, R.S.; Harris, E.D.; Burnett, J.B.; Gerber, D.A. 1977: Treatment of rheumatoid arthritis with L-histidine: a randomized, placebo-controlled, double-blind trial Journal of Rheumatology 4(4): 414-419
Yang, J.L. 1993: Auranofin in the treatment of rheumatoid arthritis: a multicenter double-blind prospective clinical trial Zhonghua Nei Ke Za Zhi 32(7): 486-488
Berkowitz, S.S.; Bernhard, G.; Bilka, P.J.; Blechman, W.J.; Marchesano, J.M.; Rosenthal, M.; Wortham, G.F. 1974: Tolmetin versus placebo for the treatment of rheumatoid arthritis: a sequential double-blind clinical trial Current Therapeutic Research 16(5): 442-451
Petrick, T.J.; Black, M.E. 1983: Double-blind multicenter studies with meclofenamate sodium in the treatment of rheumatoid arthritis in the United States and Canada Arzneimittel-Forschung 33(4a): 631-635
Furuya, T. 2014: Epidemiology of bone and joint disease - the present and future - . Risk factors for fractures and treatment of osteoporosis in Japanese patients with rheumatoid arthritis Clinical Calcium 24(5): 743-749
Tanchyk, A.P. 1986: Prevention of tooth erosion from salicylate therapy in juvenile rheumatoid arthritis General Dentistry 34(6): 479-480
Novikova, D.S.; Popkova, T.V.; Nasonov, E.L. 2011: Current knowledge about pathogenesis and treatment of arterial hypertension in rheumatoid arthritis Terapevticheskii Arkhiv 83(5): 24-33
Sewerin, P.; Müller-Lutz, A.; Abrar, D.Benjamin.; Odendahl, S.; Eichner, M.; Schneider, M.; Ostendorf, B.; Schleich, C. 2019: Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis Clinical and Experimental Rheumatology 37(2): 179-185
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633
Bick, R.L.; Haas, S.K. 1998: International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997 Medical Clinics of North America 82(3): 613-633